Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
43,165,134
-
Shares change
-
-355,116
-
Total reported value, excl. options
-
$1,009,755,964
-
Value change
-
-$20,822,724
-
Put/Call ratio
-
43%
-
Number of buys
-
114
-
Number of sells
-
-68
-
Price
-
$23.40
Significant Holders of AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) as of Q1 2016
214 filings reported holding AMAG - AMAG PHARMACEUTICALS INC - COMMON STOCK as of Q1 2016.
AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,165,134 shares
.
Largest 10 shareholders include FMR LLC (4,205,703 shares), BlackRock Fund Advisors (2,930,434 shares), Palo Alto Investors, LLC (2,906,194 shares), VANGUARD GROUP INC (2,734,502 shares), JANUS CAPITAL MANAGEMENT LLC (2,684,317 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,251,807 shares), PUTNAM INVESTMENTS LLC (1,970,591 shares), D. E. Shaw & Co., Inc. (1,965,460 shares), STATE STREET CORP (1,622,135 shares), and STELLIAM INVESTMENT MANAGEMENT, LP (1,470,000 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.